— Dycom Industries Inc. (NYSE: DY) reported its third-quarter 2020 adjusted earnings of $0.88 per share versus $0.72 per share expected.
— Contract revenues rose by 4.2% to $884.1 million versus $849.9 million expected. The contract revenues increased by 4.7% on an organic basis after excluding $3.9 million in contract revenues from storm restoration services.
— Adjusted EBITDA decreased to $91.7 million from $98.6 million in the previous year quarter.
— Looking ahead into the fourth quarter, the company now expects total contract revenues in the range of $700-740 million compared to the consensus estimates of $747.28 million.
— For the fourth quarter, the net loss is predicted to be in the range of $0.27-0.10 per share and adjusted per-share results are anticipated to be between a loss of $0.15 and a profit of $0.02. The consensus estimates EPS of $0.10.
— The company had solid liquidity of $219.6 million at the end of Q3 2020 consisting of availability under the senior credit facility and cash on hand.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
